Floatz logo

ZIPRASIDONE

Depression, Bipolar

Queen's UniversitySmall moleculePhase 4 / ApprovedDormant
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Depression, Bipolar cohort.

Asset / SponsorPhaseRating
Olanzapine
China Medical University, China
Phase 4BBB
Cariprazine
Aalborg University Hospital
Phase 4BB
Valproic Acid
Ewha Womans University Mokdong Hospital
Phase 4BB
Starch
China Medical University, China
Phase 4BB
FLUOXETINE
Eli Lilly and Company
Phase 4BB

View all 23 →

Same molecule, other indications

ZIPRASIDONE is also rated in:

schizoaffective disorderDormant
BBB
Indicative ·
76 / 100
View asset →
psychotic disorderDormant
BB
Indicative ·
71 / 100
View asset →
Affective DisordersDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →